Draft Genome Sequences of Antimicrobial-Resistant Shigella Clinical Isolates from Pakistan

Sara Lomonaco; Christine Lascols; Matthew A Crawford; Kevin Anderson; David R Hodge; Debra J Fisher; Segaran P Pillai; Stephen A Morse; Erum Khan; Molly A Hughes; Marc W Allard; Shashi K Sharma

doi:10.1128/MRA.00500-19

Draft Genome Sequences of Antimicrobial-Resistant Shigella Clinical Isolates from Pakistan

Microbiol Resour Announc. 2019 Jul 25;8(30):e00500-19. doi: 10.1128/MRA.00500-19.

Authors

Sara Lomonaco¹, Christine Lascols^{2

3}, Matthew A Crawford⁴, Kevin Anderson⁵, David R Hodge⁵, Debra J Fisher⁴, Segaran P Pillai⁶, Stephen A Morse³, Erum Khan⁷, Molly A Hughes⁴, Marc W Allard⁸, Shashi K Sharma⁸

Affiliations

¹ Division of Microbiology, Office of Regulatory Science, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, Maryland, USA sara.lomonaco@fda.hhs.gov.
² National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
³ IHRC, Inc., Atlanta, Georgia, USA.
⁴ Department of Medicine, Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA.
⁵ Science and Technology Directorate, U.S. Department of Homeland Security, Washington, DC, USA.
⁶ Office of the Commissioner, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
⁷ Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan.
⁸ Division of Microbiology, Office of Regulatory Science, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, Maryland, USA.

Abstract

Shigella spp. are the most common cause of dysentery in developing countries and the second leading cause of diarrheal deaths worldwide. Multidrug-resistant (MDR) Shigella spp. are a serious threat to global health. Herein, we report draft genome sequences for three MDR Shigella isolates from Pakistan, two Shigella flexneri isolates and one Shigella sonnei isolate.

Grants and funding

R21 AI139947/AI/NIAID NIH HHS/United States